Leflunomide manages rheumatoid arthritis symptoms by calming the immune system. Reducing inflammation helps prevent joint damage, providing physical relief for individuals living with this inflammatory condition.
When inflammation targets the joints, many people notice swelling, stiffness, and reduced mobility. Leflunomide belongs to a class of drugs called immunomodulators, which help temper an overactive immune response. Its primary therapeutic role is to reduce the activity of immune cells that contribute to joint damage. This active compound is found in medicines such as Arava, which are used under medical supervision in Singapore.
The chemical structure of leflunomide allows it to interfere with the growth of certain immune cells, thereby slowing the progression of inflammatory joint disease. By limiting this cellular activity, the medication can help manage pain and protect joints from further injury over time. It is not a cure, but it can assist with symptom control in chronic conditions.
Various brand options include Arava, which lists leflunomide as its sole active ingredient. In Singapore, the drug is supplied in tablet form, typically taken once daily after meals. Both brand-name and generic versions contain the same molecule, though packaging and price may differ. Patients receive the medication through pharmacies after a healthcare professional determines its suitability.
People experiencing persistent joint pain and swelling often receive leflunomide as part of their treatment plan. The medication is commonly used for rheumatoid arthritis, a condition where the immune system attacks joint linings. It may also be considered for other autoimmune disorders such as psoriatic arthritis and certain types of vasculitis. Generally, adults with moderate to severe disease activity are the ones who are prescribed leflunomide-containing medicines.
The drug works by blocking an enzyme needed for the production of new immune cells. With fewer cells available to drive inflammation, the overall attack on joint tissue diminishes. This reduction in immune activity translates into less pain, stiffness, and swelling for many patients. The effect is gradual, often noticeable after several weeks of consistent use.
Mild stomach upset, headache, and occasional skin rashes are among the most frequently reported experiences. Some people notice temporary dizziness or mild increases in liver enzyme tests, which are usually monitored by the prescribing clinician.
Rarely, leflunomide can cause severe liver problems, serious infections, or low blood cell counts. Warning signs include persistent yellowing of the skin or eyes, unusual bruising, fever, or persistent cough. If any of these occur, urgent medical attention is recommended.
Pregnancy, planned pregnancy, or breastfeeding are strong contraindications because the drug can affect fetal development. Individuals with a history of serious liver disease or severe kidney impairment should avoid leflunomide. Known allergy to the medication or its components also warrants caution.
Alcohol use can increase the risk of liver irritation when combined with leflunomide. Certain medicines that suppress the immune system or affect liver function may interact, so checking the specific medication label is important. Readers should refer to their medication’s package insert for detailed interaction information.
If you store leflunomide tablets, keep them in a dry place away from direct sunlight and out of reach of children. Treatment duration varies; some patients use the drug for several years while others may discontinue based on disease response. Different formulations of Arava may have slight variations in dose strength, so always follow the information provided with your specific product. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of leflunomide and is not medical advice. Medicines containing this active ingredient, such as Arava, may differ in formulation, strength, and directions for use. The information presented does not replace professional judgment and the author disclaims any liability for clinical application. Readers should review the labeling of their specific medication and seek guidance from a healthcare professional.
For more detailed reading, see the following resources:
